BerGenBio Company
BerGenBio is clinical-stage biopharma developing first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.
Industry:
Small&Large Molecules
Headquarters:
Bergen, Hordaland, Norway
Founded Date:
2007
Register and Claim Ownership